If you missed our Fall Mixer Event, HighRes Creative Agency captured the Panel Discussion on The Future of Psychedelics in Illinois in an excellent video. Watch it now to learn more about how we can shape the future of mental health together, and if you want to support the CURE Act, visit http://www.illinoispsychedelicsociety.org/cureact |
|
|
Thank you to our valued partners for making this event possible: Sana Healing Collective Students for Sensible Drug Policy Hopemark Health Relief Mental Health Willow & Leaf Counseling Imagine Healthcare |
|
|
Tonight, experienced trip sitter, doula, and teacher, Catherine Durkin Robinson will show you how psychedelics help people reduce fears and anxiety over death in many different ways. Together, we will discuss several types of psychedelics and plant medicine, what the studies show, and other ways to reduce emotional and spiritual suffering at the end of life. | | |
|
|
Healthcare Professional Perspectives on Psychedelics On Saturday, join this clinical discussion on Potentials for Harm and Good. All proceeds from ticket sales and donations from this event benefit the Integrative Medicine Program Education Fund. Registrants will receive a recording of the presentation.
| | |
|
|
Join us December 10th at the historic Bilandic Building for a pivotal discussion on the future of mental health in Illinois. Learn how the CURE Act could pave the way for psychedelic-assisted therapies.This hearing, hosted by State Representative Lindsey LaPointe, will feature clinical perspectives, personal testimonies, and legislative updates. Don’t miss this opportunity to support groundbreaking advancements in mental health care! | | |
|
|
CALL TO ACTION! Your voice is powerful, and now is the time to make it heard! By filing a witness slip, you can officially show your support for the CURE Act and help push this groundbreaking legislation forward.
| | |
|
|
Together, we can make history. Thank you for being a part of this movement! |
|
|
Massachusetts Ballot Initiative Fails |
|
|
In the November 2024 elections, Massachusetts voters considered Question 4, a ballot initiative aimed at legalizing and regulating certain natural psychedelics, including psilocybin, for therapeutic use. Despite significant advocacy and public interest, the measure was ultimately rejected by the electorate. Read More Here. This outcome highlights the ongoing national debate surrounding the therapeutic potential and legal status of psychedelics. While some states have moved toward decriminalization and regulated use, others remain cautious. The Massachusetts decision underscores the importance of continued education and advocacy to inform public opinion and policy development in this evolving field. For Illinois, this serves as a pertinent example as we advance discussions on the CURE Act and the future of psychedelic-assisted therapies within our state. Understanding the complexities and public sentiments in other regions can guide our efforts to promote informed and balanced approaches to psychedelic policy and mental health treatment. |
|
|
Psychedelic Mushrooms Market Growth |
|
|
The psychedelic mushrooms market is projected to more than double in size by 2031, growing from $1.5 billion in 2024 to an estimated $3.3 billion. This growth is driven by increasing scientific research, evolving regulatory environments, and growing interest in psilocybin as a potential mental health treatment. Read More Here |
|
|
FDA Fast-Tracks LSD for Anxiety Treatment |
|
|
The FDA has granted breakthrough therapy designation to MindMed's LSD-based treatment for anxiety, known as MM120. This designation is given to drugs that have demonstrated substantial improvement over existing treatments, highlighting the therapeutic potential of psychedelics in mental health care. Read More Here |
|
|
Psychedelics and End-of-Life Care |
|
|
Recent studies suggest that psychedelics like LSD, psilocybin, and MDMA may help alleviate anxiety, depression, and existential distress in terminally ill patients. These findings indicate potential benefits for end-of-life care, though further research is needed to fully understand their efficacy and safety. Read More Here |
|
|
Psychedelics and Sexual Health |
|
|
Recent studies suggest that psychedelics like LSD, psilocybin, and MDMA may help alleviate anxiety, depression, and existential distress in terminally ill patients. These findings indicate potential benefits for end-of-life care, though further research is needed to fully understand their efficacy and safety. Read More Here |
|
|
When you support IPS, you help expand access to life-changing psychedelic therapies. Every contribution matters! |
|
|
|
|